Immunomodulatory aspects of photodynamic therapy

Expert Opinion on Investigational Drugs

Volumn 7, Issue 1, 1998, Pages 57-64

  Hunt, D W C ^a   Levy, J G ^a  

^a QLT PhotoTherapeutics Inc   (Canada)

Author keywords

Antigen presenting cells; Autoimmunity; Benzoporphyrin derivative; Contact hypersensitivity; Immune modulation; Photodynamic therapy; Photofrin ; Photosensitisers; Porphyrins; Receptor down regulation

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CYTOKINE; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNITY; CANCER; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; TUMOR NECROSIS;

EID: 0031963353     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.1.57     Document Type: Review

References (48)